20/20 Biolabs Inc. AIDX

 — 
0.43 0.01 2.38% as of 25 Sep
Market cap
$5.4M
P/E
0.0×
Dec '24 Dec '25
P/E ratio
0.00 0.00
P/S ratio
0.00 0.00
P/FCF ratio
0.00 0.00
P/Operating CF
(59.91) (59.91)
P/B ratio
0.00 0.00
EV/Sales
0.00 0.00
EV/EBITDA
0.00 0.00
EV/FCF
(20.70) (20.70)
Current Ratio
1.50 0.60
Net Debt/EBITDA
0.32 0.11
Debt/Equity
0.00 (36.15)
ROE
0.00% (537.07%)
ROA
0.00% (96.84%)
ROIC
0.00% 0.00%
Return on Tangible Assets
(697.63%) 399.74%
Average Days of Receivables
28.18 35.70
Earnings Yield
(158.71%) (158.71%)
Free Cash Flow Yield
(4.82%) (4.82%)
Free Cash Flow per Share
(0.54) (0.39)
Book value per Share
0.31 0.00
Free Cash Flow
(2.60) (1.92)
EV/EBIT
0.00 0.00
Other line items

Show all line items

Columns are period end dates